JP2021523934A5 - - Google Patents
Info
- Publication number
- JP2021523934A5 JP2021523934A5 JP2021506391A JP2021506391A JP2021523934A5 JP 2021523934 A5 JP2021523934 A5 JP 2021523934A5 JP 2021506391 A JP2021506391 A JP 2021506391A JP 2021506391 A JP2021506391 A JP 2021506391A JP 2021523934 A5 JP2021523934 A5 JP 2021523934A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound
- salt
- phenyl
- alkenyl
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862660880P | 2018-04-20 | 2018-04-20 | |
| US62/660,880 | 2018-04-20 | ||
| PCT/US2019/028560 WO2019204819A1 (en) | 2018-04-20 | 2019-04-22 | Aminopyrazines and related compounds useful as mitochondrial uncouplers |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021523934A JP2021523934A (ja) | 2021-09-09 |
| JP2021523934A5 true JP2021523934A5 (https=) | 2022-04-25 |
| JPWO2019204819A5 JPWO2019204819A5 (https=) | 2022-04-25 |
Family
ID=67139787
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506388A Pending JP2021522327A (ja) | 2018-04-20 | 2019-04-22 | ミトコンドリア脱共役剤として有用なオキサジアゾロピラジンおよびオキサジアゾロピリジン |
| JP2021506390A Pending JP2021523933A (ja) | 2018-04-20 | 2019-04-22 | ミトコンドリア脱共役剤として有用なイミダゾピリジン |
| JP2021506391A Pending JP2021523934A (ja) | 2018-04-20 | 2019-04-22 | ミトコンドリア脱共役剤として有用なアミノピラジンおよび関連化合物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021506388A Pending JP2021522327A (ja) | 2018-04-20 | 2019-04-22 | ミトコンドリア脱共役剤として有用なオキサジアゾロピラジンおよびオキサジアゾロピリジン |
| JP2021506390A Pending JP2021523933A (ja) | 2018-04-20 | 2019-04-22 | ミトコンドリア脱共役剤として有用なイミダゾピリジン |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20210253594A1 (https=) |
| EP (3) | EP3781572A1 (https=) |
| JP (3) | JP2021522327A (https=) |
| KR (3) | KR20210003831A (https=) |
| CN (3) | CN112262141A (https=) |
| AU (2) | AU2019256722A1 (https=) |
| BR (2) | BR112020021466A2 (https=) |
| CA (2) | CA3097751A1 (https=) |
| IL (2) | IL278070A (https=) |
| MX (2) | MX2020011050A (https=) |
| WO (3) | WO2019204813A1 (https=) |
| ZA (2) | ZA202006295B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112262141A (zh) * | 2018-04-20 | 2021-01-22 | 弗吉尼亚理工大学知识产权有限公司 | 可用作线粒体解偶联剂的咪唑吡啶 |
| WO2020191503A1 (en) * | 2019-03-27 | 2020-10-01 | Algernon Pharmaceuticals Inc. | Methods and uses of bromantane and derivatives thereof for treating lung disease, fatty liver disease, and kidney disorders |
| CA3189027A1 (en) | 2020-07-11 | 2022-01-20 | Pfizer Inc. | Antiviral heteroaryl ketone derivatives |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
| EP4482494A4 (en) * | 2022-02-21 | 2026-02-25 | Univ Colorado Regents | RE-SENSITIZATION OF MULTI-DRUG-RESISTANT GRAM-NEGATIVE (MDR) BACTERIA TO COLISTIN USING IONOPHORES |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2501680A1 (fr) | 1981-03-12 | 1982-09-17 | Elf Aquitaine | Synthese de tetra mercaptides stanniques |
| US4472840A (en) | 1981-09-21 | 1984-09-25 | Jefferies Steven R | Method of inducing osseous formation by implanting bone graft material |
| US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
| LU84979A1 (fr) | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
| US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
| US5606019A (en) | 1987-10-29 | 1997-02-25 | Protien Polymer Technologies, Inc. | Synthetic protein as implantables |
| JP2668259B2 (ja) * | 1988-02-18 | 1997-10-27 | 塩野義製薬株式会社 | 複素環化合物および抗潰瘍剤 |
| GB2215209B (en) | 1988-03-14 | 1992-08-26 | Osmed Inc | Method and apparatus for biodegradable, osteogenic, bone graft substitute device |
| US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| JPH0327172A (ja) | 1989-06-19 | 1991-02-05 | Nissan Chem Ind Ltd | 布の漂白方法 |
| US5645591A (en) | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
| JPH0741461A (ja) * | 1993-05-27 | 1995-02-10 | Eisai Co Ltd | スルホン酸エステル誘導体 |
| WO2000052001A1 (en) * | 1999-03-03 | 2000-09-08 | Samjin Pharmaceutical Co., Ltd. | Piperazine derivatives and process for the preparation thereof |
| CN1231473C (zh) * | 2000-02-16 | 2005-12-14 | 神经能质公司 | 取代的芳基吡嗪 |
| AU2001288623A1 (en) | 2000-09-05 | 2002-03-22 | Tularik, Inc. | Fxr modulators |
| US20060004010A1 (en) * | 2002-07-10 | 2006-01-05 | Hiromu Habashita | Ccr4 antagonist and medical use thereof |
| EP1529531A1 (en) * | 2003-11-04 | 2005-05-11 | 4Sc Ag | Oxadiazolopyrazine derivatives as pharmaceutically active compounds |
| WO2005044270A1 (en) | 2003-11-04 | 2005-05-19 | 4Sc Ag | Oxadiazolopyrazine derivatives as pharmaceutically active compounds |
| JP2008515979A (ja) * | 2004-10-14 | 2008-05-15 | コンパス ファーマシューティカルズ リミティド ライアビリティ カンパニー | フラザノ‘３，４−ビピラジン（ｂｉｐｙｒａｚｉｎｅ）及び抗腫瘍剤としてのその使用 |
| WO2006124874A2 (en) | 2005-05-12 | 2006-11-23 | Kalypsys, Inc. | Inhibitors of b-raf kinase |
| ES2270715B1 (es) * | 2005-07-29 | 2008-04-01 | Laboratorios Almirall S.A. | Nuevos derivados de pirazina. |
| US8329704B2 (en) * | 2005-12-21 | 2012-12-11 | Janssen Pharmaceutica, N.V. | Substituted pyrazinone derivatives for use in MCH-1 mediated diseases |
| EP2017277A1 (en) * | 2007-06-29 | 2009-01-21 | 4Sc Ag | Thiophene-imidazopyridines |
| CA2709784A1 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| CA2759795C (en) * | 2009-04-30 | 2016-11-29 | Midwestern University | Method and composition for treating diabetic ketoacidosis |
| EP2604260B1 (en) * | 2010-08-10 | 2017-05-10 | Shionogi&Co., Ltd. | Novel heterocyclic derivatives and pharmaceutical composition containing same |
| RU2014120166A (ru) * | 2011-10-20 | 2015-11-27 | ГЛЭКСОСМИТКЛАЙН ЭлЭлСи | Замещенные бициклические аза-гетероциклы и их аналоги в качестве модуляторов сиртуина |
| KR101481952B1 (ko) * | 2012-04-13 | 2015-01-22 | 한국과학기술연구원 | 신경보호제로서의 유레아 유도체 |
| WO2013192388A1 (en) * | 2012-06-20 | 2013-12-27 | University Of Virginia Patent Foundation | Compositions and methods for regulating glucose homeostasis and insulin action |
| TW201441203A (zh) | 2012-11-05 | 2014-11-01 | Medeia Therapeutics Ltd | Ｎ－取代４－胺苯酚及對應醌亞胺 |
| WO2015000715A1 (en) * | 2013-07-02 | 2015-01-08 | Syngenta Participations Ag | Pesticidally active bi- or tricyclic heterocycles with sulfur containing substituents |
| KR101428622B1 (ko) * | 2014-01-07 | 2014-08-13 | 국방과학연구소 | 옥사디아졸로 피라진기를 포함하는 화합물 또는 염을 포함하는 리튬 이차 전지용 전극 및 이를 포함하는 리튬 이차 전지 |
| MX2017005158A (es) | 2014-10-28 | 2017-07-27 | Shionogi & Co | Derivado heterociclico que tiene actividad de activacion de proteina cinasa activada por adenosina monofostato (ampk). |
| JP2018500388A (ja) * | 2014-11-18 | 2018-01-11 | ラットガーズ、ザ ステート ユニバーシティ オブ ニュージャージー | 代謝疾患及び癌の治療のための、新規ミトコンドリアアンカップラー |
| WO2017151063A1 (en) * | 2016-03-03 | 2017-09-08 | Agency For Science, Technology And Research | Use of furazano[3,4-b]pyrazine derivatives for chemotherapy |
| TWI754702B (zh) * | 2016-12-28 | 2022-02-11 | 德商Ｕｃｂ製藥有限公司 | （氮雜）吲哚－和苯並呋喃－３－磺醯胺類 |
| JP2020520949A (ja) * | 2017-05-22 | 2020-07-16 | ユニバーシティ オブ ヴァージニア パテント ファウンデーションＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｖｅｒｇｉｎｉａ Ｐａｔｅｎｔ Ｆｏｕｎｄａｔｉｏｎ | 組成物、並びにミトコンドリア脱共役剤を調製及び使用する方法 |
| CN112262141A (zh) * | 2018-04-20 | 2021-01-22 | 弗吉尼亚理工大学知识产权有限公司 | 可用作线粒体解偶联剂的咪唑吡啶 |
-
2019
- 2019-04-22 CN CN201980038722.7A patent/CN112262141A/zh active Pending
- 2019-04-22 JP JP2021506388A patent/JP2021522327A/ja active Pending
- 2019-04-22 KR KR1020207033297A patent/KR20210003831A/ko not_active Withdrawn
- 2019-04-22 MX MX2020011050A patent/MX2020011050A/es unknown
- 2019-04-22 EP EP19735420.2A patent/EP3781572A1/en active Pending
- 2019-04-22 US US17/048,897 patent/US20210253594A1/en not_active Abandoned
- 2019-04-22 CN CN201980038852.0A patent/CN112261941A/zh active Pending
- 2019-04-22 MX MX2020011049A patent/MX2020011049A/es unknown
- 2019-04-22 US US17/049,145 patent/US20210253538A1/en not_active Abandoned
- 2019-04-22 BR BR112020021466-3A patent/BR112020021466A2/pt not_active Application Discontinuation
- 2019-04-22 EP EP19789309.2A patent/EP3781165A4/en not_active Withdrawn
- 2019-04-22 AU AU2019256722A patent/AU2019256722A1/en not_active Abandoned
- 2019-04-22 AU AU2019256719A patent/AU2019256719A1/en not_active Abandoned
- 2019-04-22 WO PCT/US2019/028544 patent/WO2019204813A1/en not_active Ceased
- 2019-04-22 KR KR1020207033337A patent/KR102913366B1/ko active Active
- 2019-04-22 US US17/049,232 patent/US11708376B2/en active Active
- 2019-04-22 JP JP2021506390A patent/JP2021523933A/ja active Pending
- 2019-04-22 BR BR112020021469-8A patent/BR112020021469A2/pt not_active Application Discontinuation
- 2019-04-22 WO PCT/US2019/028560 patent/WO2019204819A1/en not_active Ceased
- 2019-04-22 CA CA3097751A patent/CA3097751A1/en active Pending
- 2019-04-22 JP JP2021506391A patent/JP2021523934A/ja active Pending
- 2019-04-22 CN CN201980038732.0A patent/CN112262146A/zh active Pending
- 2019-04-22 EP EP19735421.0A patent/EP3781567B1/en active Active
- 2019-04-22 KR KR1020207033356A patent/KR102900692B1/ko active Active
- 2019-04-22 CA CA3097752A patent/CA3097752A1/en active Pending
- 2019-04-22 WO PCT/US2019/028555 patent/WO2019204816A1/en not_active Ceased
-
2020
- 2020-10-09 ZA ZA2020/06295A patent/ZA202006295B/en unknown
- 2020-10-09 ZA ZA2020/06296A patent/ZA202006296B/en unknown
- 2020-10-15 IL IL278070A patent/IL278070A/en unknown
- 2020-10-15 IL IL278069A patent/IL278069A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021523934A5 (https=) | ||
| CN101622231B (zh) | 作为葡糖激酶激活剂的2，2，2-三取代的乙酰胺衍生物、它们的制造方法和药学应用 | |
| CA2463569C (en) | Activator for peroxisome proliferator-activated receptor .delta. | |
| ES2277142T3 (es) | Compuesto de dibencilamina y su uso medicinal. | |
| JP5786034B2 (ja) | 脂質異常症の治療に適したヘテロ環式化合物 | |
| EP2917190B1 (en) | New benzene sulfonamide thiazole compounds | |
| JP5340745B2 (ja) | アントラニルアミド／２−アミノ−ヘテロアレーンカルボキサミド誘導体 | |
| RU2496776C2 (ru) | Тиазольное производное и его применение в качестве ингибитора vap-1 | |
| IL149582A (en) | SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME AND THEIR USE FOR THE MANUFACTURE OF MEDICAMENTS FOR THE TREATMENT OF hPPAR ALPHA DISEASE OR CONDITION | |
| EP2215049A1 (en) | P2x3, receptor antagonists for treatment of pain | |
| JP2013501074A5 (https=) | ||
| TW200806643A (en) | Thiazole and thiadiazole compounds for inflammation and immune-related uses | |
| TWI691475B (zh) | Ｕｒａｔ１抑制劑 | |
| CA3029489A1 (en) | 1h-pyrazol-1-yl-thiazoles as inhibitors of lactate dehydrogenase and methods of use thereof | |
| JP2015536306A5 (https=) | ||
| JP2021522327A5 (https=) | ||
| JP2010540462A5 (https=) | ||
| RU2013130879A (ru) | Производные оксазолилметилового эфира в качестве агонистов рецептора alx | |
| JP2021523933A5 (https=) | ||
| JPWO2019204819A5 (https=) | ||
| JP2007126454A (ja) | アニリド誘導体 | |
| CN105008337B (zh) | 具有改善的体内功效的作为nep抑制剂的取代的联苯基丁酸衍生物 | |
| HUP0400043A2 (hu) | HPPAR-alfa receptor aktiváló hatású oxazol/tiazol-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| JP3630676B2 (ja) | ジベンジルアミン化合物及びその医薬用途 | |
| JP2014532656A (ja) | 炎症および免疫関連用途のための化合物 |